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A B S T R A C T
Background
Congenital toxoplasmosis is considered a rare but potentially severe infection. Prenatal education about congenital toxoplasmosis could
be the most efficient and least harmful intervention, yet its effectiveness is uncertain.
Objectives
To assess the effects of prenatal education for preventing congenital toxoplasmosis.
Search methods
We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register (31 May 2015), and reference lists of relevant papers,
reviews and websites.
Selection criteria
Randomized and quasi-randomized controlled trials of all types of prenatal education on toxoplasmosis infection during pregnancy.
Cluster-randomized trials were eligible for inclusion.
Data collection and analysis
Two review authors independently assessed trials for inclusion and risk of bias, extracted data and checked them for accuracy.
Main results
Two cluster-randomized controlled trials (RCTs) (involving a total of 5455 women) met the inclusion criteria. The two included trials
measured the effectiveness of the intervention in different ways, which meant that meta-analysis of the results was not possible. The
overall quality of the two studies, as assessed using the GRADE approach, was low, with high risk of detection and attrition bias in
both included trials.
One trial (432 women enrolled) conducted in Canada was judged of low methodological quality. This trial did not report on any of
the review’s pre-specified primary outcomes and the secondary outcomes reported results only as P values. Moreover, losses to follow-
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up were high (34%, 147 out of 432 women initially enrolled). The authors concluded that prenatal education can effectively change
pregnant women’s behavior as it increased pet, personal and food hygiene. The second trial conducted in France was also judged of low
methodological quality. Losses to follow-up were also high (44.5%, 2233 out of 5023 women initially enrolled) and differential (40%
in the intervention group and 52% in the control group). The authors concluded that prenatal education for congenital toxoplasmoses
has a significant effect on improving women’s knowledge, whereas it has no effect on changing women’s behavior. In this trial 17/3949
pregnant women seroconverted for toxoplasmosis: 13/2591 (0.5%) in the intervention group and 4/1358 (0.3%) in the control group.
The rate of seroconversion detected during the study did not differ between groups (risk ratio (RR) 1.70, 95% confidence interval (CI)
0.56 to 5.21; participants = 3949; studies = one, low quality evidence). The number of events was too small to reach conclusions about
the effect of prenatal education on seroconversion rate during pregnancy.
No other randomized trials on the effect of prenatal education on congenital toxoplasmosis rate, or toxoplasmosis seroconversion rate
during pregnancy were detected.
Authors’ conclusions
Even though primary prevention of congenital toxoplasmosis is considered a desirable intervention, given the lack of related risks
compared to secondary and tertiary prevention, its effectiveness has not been adequately evaluated. There is very little evidence from
RCTs that prenatal education is effective in reducing congenital toxoplasmosis even though evidence from observational studies suggests
it is. Given the lack of good evidence supporting prenatal education for congenital toxoplasmosis prevention, further RCTs are needed
to confirm any potential benefits and to further quantify the impact of different sets of educational intervention.
P L A I N L A N G U A G E S U M M A R Y
Prenatal education for congenital toxoplasmosis
Toxoplasmosis infection is caused by a parasite, Toxoplasma gondii. Eating or handling raw or insufficiently-cooked meat, not washing
hands thoroughly after gardening, handling contaminated soil or water, or contact with cats’ faeces can cause infection. Usually it is
asymptomatic and self-limiting. Primary prevention involves educating the general public, filtering water and improving farm hygiene
to reduce animal infection.
If pregnant women have not previously been exposed to the parasite and develop antibodies while pregnant, the infection can be
transmitted from the mother to the fetus (congenital toxoplasmosis). This is rare but potentially has serious consequences such as
malformation, mental retardation, deafness and blindness of the infected infant, intrauterine death or stillbirth. The probability of
infection is greater during the third trimester but the risk of the fetus developing major clinical signs is greater early in pregnancy.
Pregnant women are often unaware of risk factors for congenital toxoplasmosis. Offering prenatal education could mean that women
adopt simple behavioral measures to avoid toxoplasmosis.
This review included two randomized controlled trials (involving 5455 women). Data could not be combined because each trial
measured effectiveness in different ways. One study was from Canada and involved 432 women randomly assigned to a 10-minute
presentation during a prenatal class about toxoplasmosis prevention or to a usual prenatal class. Losses to follow-up were high and 285
completed the post-test questionnaire in the third trimester. Only 5% of the intervention women recalled having obtained information
on toxoplasmosis prevention during prenatal classes. However, the authors concluded that prenatal education can effectively change
pregnant women’s behavior as it increased pet, personal and food hygiene. The other trial conducted in France involved 5023 pregnant
women with no evidence of toxoplasmosis infection (seronegative) who were randomly assigned to receive a brochure and an audiotape
containing information for toxoplasmosis prevention, or to a usual prenatal class. Losses to follow-up were high and 2790 completed
both pre-test and post-test questionnaire on behavior (44.5% loss to follow-up), whereas 3949 women were tested for blood antibodies
(22.4% loss to follow-up). Women’s behavior did not change after the intervention. Similarly, the seroconversion rate did not differ
between groups (13 out of 2591 women seroconverted in the intervention and four out of 1358 in the control group).
Both trials were judged as having low methodological quality as assessed by the GRADE approach. This limits our confidence in the
results. Evidence supporting prenatal education to prevent congenital toxoplasmosis is therefore limited.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Educational prenatal classes compared with usual prenatal classes for prenatal education for congenital toxoplasmosis
Patient or population: women of reproductive age, irrespective of their pregnant status
Settings: Ontario, Canada
Intervention: educational prenatal classes
Comparison: usual prenatal classes
Outcomes Comments
Rate of congenital toxoplasmosis, defined by persistence of specific
IgG antibodies beyond 11 months of age
These outcomes were either not reported or were reported in
unusable formate for ’Summary of findings’ tables
Rate of toxoplasmosis seroconversion in pregnant women
Pregnant women knowledge of risk factors for acquiring toxoplas-
mosis infection as objectively measured through specific question-
naire
Pregnant women’s awareness of the importance of avoiding tox-
oplasmosis during pregnancy as objectively measured through
specific questionnaire
Pregnant women behavior with respect to the avoidance of risk
factors for toxoplasmosis infection during pregnancy as objectively
measured through specific questionnaire
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk
(and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval;
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change
the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to
change the estimate.
Very low quality: We are very uncertain about the estimate.
B A C K G R O U N D
Readers may wish to refer to the following Cochrane systematic
review for further information about toxoplasmosis in pregnancy:
’Treatments for toxoplasmosis in pregnancy’ (Peyron 1999).
Description of the condition
Congenital toxoplasmosis is a rare (NSC 2001), but potentially
severe parasitic infection that can lead to intrauterine death or still-
birth,malformation,mental retardation, deafness and blindness of
the infected infant (Montoya 2004). Incidence of congenital toxo-
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plasmosis varies fromone to 10 per 10,000 live children inWestern
countries (Gilbert 1999; Schmidt 2006; Signorell 2006), to 16 per
1000 in Brazil (Reis 1999). The infection is caused by Toxoplasma
gondii (T. gondii). T. gondii is one of the most common infectious
pathogenic animal parasites of man, belonging to the phylum api-
complexa group (Montoya 2004). Other members of this phylum
include known human pathogens such as Plasmodium (malaria)
and Cryptosporidium. It is acquired by ingesting oocysts excreted
by cats, contaminated soil or water, or by eating the undercooked
meat of infected animals, which contain tissue cysts (Gilbert 2002;
Montoya 2004). Most cases of toxoplasmosis infection are asymp-
tomatic and self-limited except for congenital infection and im-
munocompromised patients (Montoya 2004); hence many cases
remain undiagnosed. The incubation period of acquired infection
is estimated to be within the range of four to 21 days (seven days
on average) (Rorman 2006). Serological surveys demonstrate that
worldwide exposure to T. gondii is high (30% in USA and 50% to
80% in Europe) (Rorman 2006). The susceptibility of pregnant
women (that is the rate of seronegative pregnant women) to tox-
oplasmosis varies between countries. It is up to 90% in northern
Europe, where T. gondii is not so common (Allain 1998; Gilbert
2002).When infection does occur during pregnancy,T. gondii can
be transmitted from themother to the fetus (vertical transmission)
and can lead to congenital toxoplasmosis.Multiple factors are asso-
ciated with the occurrence of congenital toxoplasmosis infection,
including route of transmission, climate, cultural behavior, eating
habits and hygenic standards (Rorman 2006). The probability of
transmission of the parasite to the fetus varies according to the
gestational age and the risk is greater during the third trimester
(from 5% at 12 weeks to 80% just before delivery) (Dunn 1999).
Conversely, the severity of the condition, that is the risk of the fe-
tus developing major clinical signs, decreases with increasing ges-
tational age (from 60% at 12 weeks to 5% just before delivery)
(Dunn 1999). Clinical features include hydrocephalus (excessive
accumulation of cerebrospinal fluid within the cranium), micro-
cephaly (abnormal smallness of the head, usually associated with
mental retardation), deafness, cerebral calcifications, seizures and
psychomotor retardation. Signs of a systemic infection may also
be present at birth, including fever, rash, and enlargement of liver
and spleen. Fetal infection can cause inflammatory lesions of the
retina and choroids that can lead to visual impairment. Moreover,
it can cause lesions of the brain leading to mental damage; more
rarely, the infection can cause the death of the fetus or the new-
born (Gilbert 2002; Montoya 2004; NSC 2001). Severe damage
in infancy occurs in 5% of congenital toxoplasmosis cases, while
intracranial or ocular lesions are observed in 20% to 30% of cases
by three years of age (Gilbert 2001).
Although there is no consensus on the most appropriate screen-
ing or treatment for congenital toxoplasmosis, three possible ap-
proaches have been proposed: prenatal screening, neonatal screen-
ing and primary prevention (Gilbert 2002). This systematic re-
view will focus on primary prevention through prenatal education
of pregnant women. Other possibilities are discussed below.
Prenatal screening
Prenatal screening (secondary prevention) is offered in some Euro-
pean countries, for example, France, Switzerland, Germany, Aus-
tria and Italy where the incidence of T. gondiimaternal infection is
more frequent, and is based on the timely detection of themother’s
infection by a serum test for toxoplasma ImmunoglobulinG (IgG)
and Immunoglobulin M (IgM) (NSC 2001). If the first prenatal
test shows signs of recent infection or a seroconversion is detected
during pregnancy, a confirmatory test is required before starting
treatmentwith spiramycin or pyrimethamine-sulfadoxine, or both
(Foulon 1999a; Gilbert 2002; Montoya 2004). Diagnosis of fe-
tal infection is performed by amniocentesis, which is known to
be associated with a 1% risk of miscarriage (Alfirevic 2003), and
testing of the amniotic fluid for the detection of the parasite or of
toxoplasma DNA by polymerase chain reaction (PCR) technique.
Congenital toxoplasmosis can also be diagnosed by cordocentesis,
that consists of drawing fetal blood from the umbilical cord, and
the detection of the parasite or specific immunoglobulin (IgM and
IgA) in the fetal blood, but the risk of complications due to the
procedure is higher (Bader 1997; Foulon 1999b; Gilbert 2002). If
fetal infection is confirmed, the parents can decide either to termi-
nate the pregnancy or to opt for drug treatment. Prenatal screen-
ing, although advocated by some as essential for reducing con-
genital toxoplasmosis (Boyer 2005), has several limitations: false-
positive toxoplasma IgM results are common, false-positive toxo-
plasma IgG are less common but also possible (Liesenfeld 1997;
Montoya 2004); moreover, the rate of false-positive test results can
increase, notably in settings where local prevalence of the infection
is lower; there can be organizational problems or problems of ac-
ceptability due to the need to repeat the serum test every four to six
weeks in seronegative women (Bader 1997); there is no evidence
that antenatal treatment is effective in reducing transmission to
the fetus nor in improving neonatal outcomes or reducing func-
tional impairment in later childhood (Gilbert 2003; Peyron 1999;
SYROCOT 2007); there are problems concerning the accuracy
of the diagnostic test for fetal infection, particularly the lack of a
standardized technique for PCR (Chabbert 2004; Foulon 1999b;
Thalib 2005). Finally, this strategy causes additional fetal losses of
healthy fetuses due to amniocentesis and to elective terminations
of pregnancy. It has been estimated that the number of additional
losses necessary to prevent one additional case of toxoplasmosis
can be as high as 18.5 in cases of universal screening in a setting
with a low incidence of T. gondii maternal infection, such as the
USA (Bader 1997).
Neonatal screening
Neonatal screening (tertiary prevention), adopted in Poland, Den-
mark and some areas of the USA (NSC 2001), consists of the
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diagnosis of newborn infection through detection of toxoplasma
specific IgM on Guthrie card blood spots. In fact, up to 90% of
infected infants are asymptomatic at birth and will show clinical
symptoms only in later life (Gilbert 2001; Wilson 1980). Current
guidelines suggest that infected infants should receive treatment
with pyrimethamine and sulfadiazine for up to one year, regardless
of symptoms (Gilbert 2002). Even if this strategy is technically
feasible and less costly than prenatal screening, it has been proven
to have a low sensitivity, even when the test is performed on serum
samples, which are more valid than the test on filter paper blood
samples currently used: neonatal screening is not able to detect
almost half of all infected infants (Gilbert 2007). Moreover, there
is no evidence that treating the infected children has any effect
(Gilbert 2002; Lebech 1999). Finally, this approach is ineffective
on irreversible damage already present at birth. Considering such
limitations, neonatal screening should be adopted only in places
where other options are not available; the implications of such
a policy should be fully discussed with the parents of the tested
newborn.
Primary prevention
Primary prevention can involve the whole population by educat-
ing the general public and filtering water, and veterinary public
health interventions (such as labeling to indicate toxoplasma-free
meat and improved farmhygiene to reduce animal infection). This
will reduce the protozoan circulation and could be an option but
up to now there is not enough research to determine the feasibility
and efficacy of this approach (Gilbert 2002; NSC 2001). Another
possibility is primary prevention based on prenatal education of
pregnant women or women of reproductive age to avoid toxoplas-
mosis in pregnancy (Gilbert 2002).
Description of the intervention
This review evaluates the effectiveness of prenatal education for
reducing the risk to develop toxoplasmosis infection during preg-
nancy. Various types of prenatal education exist and can be pro-
posed in different settings, either as a stand alone intervention or
as a component of a multifaceted intervention program and they
are all assessed in this review. Prenatal educational interventions
could include: antenatal classes provided to pregnant women, dis-
tribution of leaflets to pregnant women or to women of repro-
ductive age, irrespective of their pregnant status, one-to-one or
group counseling from different professionals (nurses, midwives,
obstetricians and gynecologists, social workers, counselors, teach-
ers, trained lay people, etc), educational intervention in schools,
mass-media campaign and others.
How the intervention might work
Primary prevention based on prenatal education, if proven to be
effective, could be a good strategy to reduce congenital toxoplas-
mosis, since it will not involve any of the problems linked to sec-
ondary and tertiary prevention strategies. In fact, sources and risk
factors for contracting toxoplasmosis are well known (Cook 2000),
and can be avoided by adopting simple behavioral measures such
as not eating raw or insufficiently cooked meat, washing hands
thoroughly after handling raw meat and after gardening, avoiding
contact with cats’ faeces (directly or indirectly through the soil,
or possibly contaminated raw vegetables or fruits) (Cook 2000;
Gilbert 2002). Nevertheless, pregnant women are often unaware
of risk factors for congenital toxoplasmosis (Ferguson 2011). If ad-
equately informed, women can bemore prone to change their own
behavior during pregnancy than during any other period of their
life; for this reason several intervention to promote healthy behav-
ior are implemented during pregnancy (see other Cochrane sys-
tematic review on pregnancy and education Chamberlain 2013).
Why it is important to do this review
When this systematic review was first published in 2009, we aimed
to synthesize available evidence on effective intervention to reduce
congenital toxoplasmosis, a rare but potentially severe condition
for which effective treatment is still lacking. Primary prevention
was theoretically considered to be, and still is, the most valuable
and safe intervention to reduce the incidence and prevalence of
this congenital infection. Unfortunately, evidence of its effective-
ness resulted to be scanty and studies poorly conducted or not ade-
quately reported. A further update of the review, although permit-
ted to add one more study to the list of included studies (Wallon
2006) did not change the conclusion: prenatal education seem to
be a promising intervention to reduce congenital toxoplasmosis
but strong evidence is lacking. This review calls for further re-
search on this relevant issue that is very likely to have an important
impact on our confidence in the estimate of effect and is likely to
change our conclusions; moreover, the systematic review provides
methodological hints for producing valuable evidence that matter
for policy makers, health professionals, and women.
O B J E C T I V E S
The primary objectives of this review were to assess the efficacy of
prenatal education to reduce the rate of:
1. new cases of congenital toxoplasmosis;
2. toxoplasmosis seroconversion during pregnancy.
Secondary objectives were to assess the efficacy of prenatal educa-
tion to increase the rate of:
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1. pregnant women’s knowledge of risk factors for acquiring
toxoplasmosis infection;
2. pregnant women’s awareness of the importance of avoiding
toxoplasmosis infection during pregnancy;
3. pregnant women’s behavior with respect to avoidance of
risk factors for toxoplasmosis infection during pregnancy.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomized and quasi-randomized controlled trials evaluating
any kind of prenatal educational intervention dealing with tox-
oplasmosis infection in pregnancy, and how to avoid it, were as-
sessed for inclusion. Studies where the control group included an
alternative intervention or no intervention were also considered
for inclusion. Studies where the unit of randomization was a group
of women (cluster-randomization) were assessed for inclusion and
analyzed as a separate group. Interventions, exclusively focused on
toxoplasmosis or interventions not exclusively focused on toxo-
plasmosis infection but where toxoplasmosis was included among
a series of different topics, were also eligible for inclusion.
Types of participants
Trials of women of reproductive age, irrespective of their pregnant
status were included. Since a screening policy for toxoplasmosis
infection is not universally adopted, studies including women, ir-
respective of their toxoplasmosis seropositive status were included.
Types of interventions
Any kind of prenatal education on toxoplasmosis infection during
pregnancy. Prenatal educational interventions could include: ante-
natal classes provided to pregnant women, distribution of leaflets
to pregnant women or to women of reproductive age, irrespec-
tive of their pregnant status, one-to-one or group counseling from
different professionals (nurses, midwives, obstetricians and gyne-
cologists, social workers, counselors, teachers, trained lay people,
etc), educational intervention in schools, mass-media campaign
and others.
Types of outcome measures
Primary outcomes
1. Rate of congenital toxoplasmosis, defined by persistence of
specific IgG antibodies beyond 11 months of age (Lebech 1996).
2. Rate of toxoplasmosis seroconversion in pregnant women,
defined by:
i) an increase in specific IgG from paired sera in
pregnant woman previously seronegative;
ii) a rising IgG titre, low IgG avidity, IgA antibodies, or a
combination of these in pregnant women who were IgG and
IgM positive at their first prenatal test (Gilbert 2002).
Secondary outcomes
1. Pregnant women’s knowledge of risk factors for acquiring
toxoplasmosis infection as objectively measured (quantitative
score) through specific questionnaire.
2. Pregnant women’s awareness of the importance of avoiding
toxoplasmosis infection during pregnancy as objectively
measured (quantitative score) through specific questionnaire.
3. Pregnant women’s behavior with respect to the avoidance of
risk factors for toxoplasmosis infection during pregnancy as
objectively measured (quantitative score) through specific
questionnaire.
Search methods for identification of studies
The followingmethods section of this review is based on a standard
template used by the Cochrane Pregnancy and Childbirth Group.
Electronic searches
We searched the Cochrane Pregnancy and Childbirth Group’s Tri-
als Register by contacting the Trials Search Co-ordinator (31 May
2015).
The Cochrane Pregnancy and Childbirth Group’s Trials Register
is maintained by the Trials Search Co-ordinator and contains trials
identified from:
1. monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL);
2. weekly searches of MEDLINE (Ovid);
3. weekly searches of Embase (Ovid);
4. monthly searches of CINAHL (EBSCO);
5. handsearches of 30 journals and the proceedings of major
conferences;
6. weekly current awareness alerts for a further 44 journals
plus monthly BioMed Central email alerts.
Details of the search strategies for CENTRAL, MEDLINE, Em-
base and CINAHL, the list of handsearched journals and confer-
ence proceedings, and the list of journals reviewed via the current
awareness service can be found in the ‘Specialized Register’ section
within the editorial information about the Cochrane Pregnancy
and Childbirth Group.
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Trials identified through the searching activities described above
are each assigned to a review topic (or topics). The Trials Search
Co-ordinator searches the register for each review using the topic
list rather than keywords.
For additional search strategy used in the previous version of this
review (Di Mario 2013), see Appendix 1.
Searching other resources
We searched the reference lists of relevant papers, reviews and web-
sites and contacted researchers working in the field for informa-
tion on any relevant studies and for any additional published or
unpublished studies.
We did not apply any language or date restrictions.
Data collection and analysis
For methods used in the previous version of this review, see Di
Mario 2013.
For this update, no new reports were identified for assessment but
we assessed the quality of evidence of the existing studies using
the GRADE approach as outlined in the GRADE Handbook. In
order to assess the quality of the body of evidence relating to the
followingoutcomes for the two comparisons: ’educational prenatal
classes compared with usual prenatal classes and brochure and an
audiotape compared with standard care’.
1. Rate of congenital toxoplasmosis.
2. Rate of toxoplasmosis seroconversion during pregnancy.
3. Pregnant women’s knowledge of risk factors for acquiring
toxoplasmosis infection.
4. Pregnant women’s awareness of the importance of avoiding
toxoplasmosis infection during pregnancy.
5. Pregnant women’s behavior with respect to avoidance of
risk factors for toxoplasmosis infection during pregnancy.
GRADEpro Guideline Development Tool was used to import
data from Review Manager 5.3 (RevMan 2014) in order to create
’Summary of findings’ tables. A summary of the intervention effect
and a measure of quality for each of the above outcomes has been
produced using the GRADE approach. The GRADE approach
uses five considerations (study limitations, consistency of effect,
imprecision, indirectness and publication bias) to assess the quality
of the body of evidence for each outcome. The evidence can be
downgraded from ’high quality’ by one level for serious (or by
two levels for very serious) limitations, depending on assessments
for risk of bias, indirectness of evidence, serious inconsistency,
imprecision of effect estimates or potential publication bias.
In future updates, if new reports are identified, we will use the
methods described in Appendix 2.
R E S U L T S
Description of studies
Results of the search
We identified 925 reports that met the initial criteria for hard
copy scrutiny. Five studies (nine reports) met the predetermined
baseline criteria of assessing an educational intervention for toxo-
plasmosis prevention. Two studies (four reports) (involving 5455
women) have been included and three studies (five reports) have
been excluded. See Figure 1 for diagram of the studies selection.
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Figure 1. Study flow diagram.
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Included studies
The first study compared two randomly allocated groups of
women and was therefore included in the review (Carter 1989).
The study was conducted in Ontario (Canada) and involved 432
pregnant women attending early prenatal classes in six centers. It
was a cluster-randomized trial, that is, a trial where groups rather
than individuals are randomized between or among comparator
interventions; in this case, the units of randomization were the
prenatal classes: 26 prenatal classes were randomly assigned to the
intervention and 26 prenatal classes were assigned to control in-
tervention (usual prenatal classes). A three-page handout was pre-
pared along with a display poster and resource materials for teach-
ers. Prenatal class instructors received one-hour basic training on
toxoplasmosis prevention. The intervention group women were
offered a 10-minute presentation focused on toxoplasmosis pre-
vention during the first prenatal class. The contents of the inter-
vention focused on cats, food, and personal hygiene.
The second study was a cluster-randomized trial conducted in
France (Wallon 2006). Women attending prenatal clinics in the
area of Lyon were enrolled if they tested seronegative for tox-
oplasma antibodies. The unit of randomization was the city.
Physicians in experimental cities provided women with a 20-page
brochure containing four pages of information of toxoplasmo-
sis plus an audiotape containing a conversation between a physi-
cian and his/her patient on issues relevant to pregnancy, including
questions on toxoplasmosis. Women attending prenatal clinics in
control cities received usual care. Knowledge and behavior were
assessed through a questionnaire administered at baseline (usually
during the third and fourth month of gestation) and at follow-up
(after delivery). Only women who completed both questionnaires
(2790 out of 5023) were included in the multivariate analysis to
identify any association between the intervention and change in
knowledge and behavior.
Excluded studies
The remaining three studies were surveys conducted at the pop-
ulation level, without a control group (before and after studies)
and were, therefore, excluded from the review as they were not
randomized controlled trials. The details of the three studies are
shown in Table 1. One study was from Belgium (Breugelmans
2004), one from Poland (Pawlowski 2001), and one from Cuba
(Molé 1992). In the Breugelmans study the intervention changed
over time: the first intervention adopted (from 1983 to 1990)
consisted of providing pregnant women with a list of recom-
mended hygiene measures to avoid toxoplasma infection during
pregnancy; thereafter (from 1991 to 2001) a leaflet containing in-
formation on congenital toxoplasmosis and how to avoid it was
given to all pregnant women in addition to the list of recommen-
dations and was assessed for effectiveness. Seroconvertion rate dur-
ing pregnancy in the intervention period was compared with the
seroconversion rate in the baseline period, when no intervention
on toxoplasmosis prevention was in place (from 1979 to 1982)
(Breugelmans 2004). The Pawlowski 2001 study used a multi-
faceted intervention including providing information to pregnant
women, refresher training for health professionals, media cam-
paigns, and the training of biology teachers in secondary schools,
over six years and their effectiveness was assessed. It was impossi-
ble to obtain the full text of the study conducted in Cuba (Molé
1992): data retrieved from the abstract indicate that an educa-
tional intervention about how to avoid toxoplasmosis infection
during pregnancy was delivered to seronegative pregnant women.
All pregnant women were enrolled at their first prenatal visit. The
number of women included in the surveys ranged from 1246 to
16,541. The Breugelmans 2004 study contained data previously
published in Foulon (Foulon 1988; Foulon 1994).
Risk of bias in included studies
We assessed the methodological quality of the included studies as
recommended in the Cochrane Handbook for Systematic Reviews
of Interventions (Higgins 2011). See Figure 2 and Figure 3 for a
summary of ’Risk of bias’ assessments.
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Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
Allocation
TheCanadian trial (Carter 1989), was a cluster-randomized trial of
low quality (Hahn 2005; Puffer 2003). The study reported that the
groups were randomized but the randomizations method was not
specified. Nevertheless, selection bias of the cluster is unlikely: the
six centers provided almost all of the prenatal education available
in that jurisdictional area; the study only lasted six months; an
equal number of classes in each center received the experimental
and the control intervention; authors stated that women in the
experimental and control groups did not differ for demographic
characteristics (even though a table reporting baseline data of the
two groups was not provided), thus there is no strong reason to
suspect that women attending prenatal classes in one period of
time differ significantly from women attending prenatal classes in
another period of time.
The second trial included (Wallon 2006) was also a cluster-ran-
domized trial of low quality: randomization method was not spec-
ified, therefore selection bias can not be excluded. The study, first
used for a master thesis, was published in a short form as a poster,
and thereafter included in a systematic review. In neither of the
publications was the statistical plan of analysis described.
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Blinding
In both trials, performance bias was assessed as being at low risk: in
both trials (Carter 1989;Wallon2006), blinding of thewomenwas
reported, but blinding of the personnel was not possible, but this
is unlikely to influence the outcome. Outcome measures referred
to changes in behavior occurring between pre-test (usually in the
first-second term of pregnancy in Carter 1989 and usually in the
third and fourth month of pregnancy in Wallon 2006) and post-
test questionnaire (in the third term of pregnancy in Carter 1989
and at delivery in Wallon 2006) in respect of hygiene measures to
avoid toxoplasmosis. Since outcome measures were self-reported,
detection bias can not be totally excluded in both of the included
trials, even if women were blinded to the objective of the study.
Incomplete outcome data
In Carter 1989, losses to follow-up at the level of women partic-
ipating in prenatal classes were 34% (432 women completed the
pre-test questionnaire and 285 completed the post-test question-
naire): women in experimental group were more likely to be lost
at follow-up than women in control group, therefore attrition bias
can not be excluded (Puffer 2003).
In Wallon 2006 overall losses to follow-up were 44.5%: women in
the control group were more likely to be lost to follow-up (52%
were lost) than women in intervention group (40% were lost),
therefore also in the second included trial attrition bias can not be
excluded (Puffer 2003).
Selective reporting
It was not clear in the two trials the extent of outcome data that
were collected and therefore, unclear whether the outcomes were
selectively reported. The primary outcomes were not reported in
one study (Carter 1989), whereas it was reported in the more
recent study (Wallon 2006).
Other potential sources of bias
Since the prenatal class instructors of the experimental and the
control group in Carter 1989 were the same, it is not possible
to exclude some contamination, even if such contaminations are
usually not an issue in cluster trials (Torgerson 2001), and in any
case, it would have acted in the sense of reducing the effect. The
total sample, considering the unit of randomization, was low (26
prenatal classes in the intervention group and 26 prenatal classes
in the control group). It is not clear from the paper if a statistical
analysis was conducted to take into account the effect of intraclus-
ter correlation. The authors did not report raw data (number or
proportion): only the P value for differences was reported.We also
contacted the authors for the original data but we did not receive
a reply. In Wallon 2006, the study method and statistical plan of
analysis were not described in detail, therefore it is not possible to
exclude other bias.
Effects of interventions
See: Summary of findings for themain comparisonEducational
prenatal classes compared with usual prenatal classes for prenatal
education for congenital toxoplasmosis; Summary of findings
2 Brochure and an audiotape compared with standard care for
prenatal education for congenital toxoplasmosis
Comparison
1) Educational prenatal classes compared with usual
prenatal classes
Primary outcomes
The study did not report any of the review pre-specified outcomes.
Secondary outcomes
The first trial included in the review (Carter 1989), reported the
following changes in behavior in the intervention group:
1. pet hygiene behavior: intervention classes reported to
behave significantly better than the control class (P value
reported < 0.05);
2. food hygiene behavior: intervention classes reported to
behave significantly better than the control class with respect to
cooking roast beef (P value reported < 0.05) and hamburgers (P
value reported < 0.01); remaining items were already good at the
pre-test;
3. personal hygiene behavior intervention classes reported to
behave significantly better than the control class only in the
subgroup of women who had professional occupations (P value
reported < 0.05); remaining professional groups and other items
considered were already good at the pre-test.
Only 5% of the women in the intervention group recall having
obtained specific information on toxoplasmosis prevention during
prenatal classes.
2) Brochure and an audiotape compared with
standard care
Primary outcomes
The second trial included in the review (Wallon 2006) reported
the following results:
1. seroconvertions for toxoplasmosis detected during the study
did not differ between groups (risk ratio (RR) 1.70, 95%
confidence interval (CI) 0.56 to 5.21; participants = 3949; one
study) (Analysis 1.1): there were 13 cases out of 2591 pregnant
women (0.5%) in the intervention group and four cases out of
1358 pregnant women (0.3%) in the control group (P = 0.35).
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2. The data above have not been adjusted for cluster design
and so it is reasonable to assume the confidence intervals have
been underestimated.
Secondary outcomes
These results were taken directly from the published report and
odds ratios (OR) appear to have been adjusted for cluster design.
1. Prenatal education on congenital toxoplasmosis was not
significantly associated to the outcome “no consumption of
undercooked meat of any type” (multiple logistic regression,
odds ratio (OR) 1.21; 95% CI 0.98 to 1.50).
2. prenatal education on congenital toxoplasmosis was not
significantly associated to the outcome “handwashing after
contact with transmission factor and before meals” (multiple
logistic regression, OR 1.01; 95% CI 0.83 to 1.22).
3. baseline behaviors concerning toxoplasmosis, smoking and
alcohol consumption were significantly associated with both the
outcomes measured, after controlling for baseline knowledge.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Brochure and an audiotape compared with standard care for prenatal education for congenital toxoplasmosis
Patient or population: women of reproductive age, irrespective of their pregnant status
Settings: France
Intervention: brochure and an audiotape
Comparison: standard care




Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Standard care brochure and an audio-
tape
Rate of toxoplasmosis se-
roconversion in pregnant
women






3 per 1000 5 per 1000
(2 to 15)
Pregnant women behav-
ior with respect to the
avoidance of risk fac-
tors for toxoplasmosis in-
fection during pregnancy
(no consumption of un-





Events were not avail-
able for these two out-
comes. OR for these two
outcomes were obtained
from a review that in-
cluded this study
Pregnant women behav-
ior with respect to the
avoidance of risk factors
for toxoplasmosis during
pregnancy (hand wash-



































































































Rate of congenital toxo-
plasmosis defined by per-
sistence of IgG antibodies
beyond 11 months
None of these outcomes were reported in the included study. If in future updates data on these outcomes are available we will include them in this SOF
Pregnant women knowl-






ness of the importance
of avoiding toxoplasmo-




*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; OR: odds ratio; RR: risk ratio
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1Evidence from one study with high risk of bias





























































































D I S C U S S I O N
Summary of main results
Twocluster-randomized trials onprimary preventionof congenital
toxoplasmosis suggest that providing specific information during
antenatal classes or prenatal visits about toxoplasmosis infection
and how to avoid it can improve pregnant women’s behavior (
Carter 1989; Wallon 2006), but the overall quality of the trials
was low.
Overall completeness and applicability of
evidence
Given the scarcity of evidence supporting the implementation of
antenatal classes for congenital toxoplasmosis, and considering
the current lack of evidence that alternative interventions such as
screening and early treatment of infected pregnant women can re-
duce the risk of congenital toxoplasmosis, further research to quan-
tify the impact of different educational interventions is needed.
Quality of the evidence
All prespecified outcomes for two comparisons were assessed and
assigned a quality rating using the GRADE methods. For the first
comparison ’educational prenatal classes compared with usual pre-
natal classes’, outcomes were either not reported or were reported
in unusable format for ’Summary of findings’ tables. Evidence
from one trial for the comparison of brochure and an audiotape
compared with standard care for the outcome of rate of toxo-
plasmosis seroconversion during pregnancy was assessed as of low
quality. Evidence for the outcome of pregnant women’s behavior
with respect to avoidance of risk factors for no consumption of
uncooked meat of any type was graded to be of moderate qual-
ity, while, for hand washing after contact with transmission factor
and before meals was graded to be of low quality. Downgrading
decisions were based in part on the high risk of bias of included
trials and imprecise results.
Potential biases in the review process
We have followed standard Cochrane methods to identify and
evaluate the studies contributing to this review, and are confident
that we have not missed any significant trials. We have sought
missing or incomplete data, and have contacted authors where
possible to clarify our interpretation of their work.
Agreements and disagreements with other
studies or reviews
When the protocol for this systematic review was firstly published
in 2006 no other systematic reviews on the effectiveness of prenatal
education for toxoplasmosis congenital prevention were available.
In 2008, a systematic review was conducted (Golloub 2008) on
this topic: six studies were described (Breugelmans 2004; Carter
1989; Foulon 2000; Nguyen 2004; Pawlowski 2001; Wallon
2006), two of which were randomized controlled trials (Carter
1989; Wallon 2006), whereas the remaining trials were observa-
tional studies (Breugelmans 2004; Foulon 2000; Nguyen 2004;
Pawlowski 2001). The authors did not provided ameta-analysis of
the data due to inconsistent reporting of results; their conclusions
are that there is some evidence that prenatal education can reduce
toxoplasmosis infection during pregnancy but that more research
on this topic is needed. In addition to the studies included in the
Golloub 2008 review, one more observational study suggests that
prenatal education might have a positive impact on reducing con-
genital toxoplasmosis (Molé 1992).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Evidence supporting prenatal education for preventing congenital
toxoplasmosis is sparse andof lowquality. Prenatal education could
have a positive effect in terms of improving women’s behavior and
reducing seroconversion during pregnancy but strong evidence
is still lacking. In settings where prenatal educative interventions
are already in place, it could be beneficial to consider offering
a specific session on how to avoid toxoplasmosis infection and
provide printed materials that are informative.
A good surveillance system should be in place whenever a prena-
tal education activity is implemented to monitor the prevalence
of seropositivity among pregnant women and to detect cases of
congenital toxoplasmosis among the offspring of women who se-
roconverted during pregnancy.
Implications for research
Given the limited evidence supporting prenatal education for con-
genital toxoplasmosis prevention, further randomized controlled
trials are needed. Given the nature of the intervention, those trials
would most probably be cluster-randomized trials, that is a trial
were groups rather than individuals are randomized between or
among comparator interventions. The studies should focus on as-
sessing the impact of different sets of intervention. The adequate
sample size to detect a reduction of the incidence of congenital
toxoplasmosis can be calculated considering at least two possible
scenarios depending on the background incidence and hypoth-
esized effect of intervention. In countries with a high incidence
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rate like Brazil (16/1000) (Reis 1999), and in countries with low
incidence rate as in western Europe (10/10,000) (Gilbert 1999),
predicting a 50% reduction of incidence in the intervention arm
of the trial (Breugelmans 2004), considering a 95% confidence
level and a 80% study power, and after doubling the sample to
take in account the design effect of the cluster-randomized trial,
the needed sample will be (EpiInfo 6):
1. countries with high incidence like Brazil: 6300 women per
arm;
2. countries with low incidence as in western Europe: 102,000
women per arm.
As results from this raw calculation, only large studies will be able
to detect a difference in terms of incidence of congenital toxoplas-
mosis; therefore, careful consideration should be given in valuing
the balance between benefits and costs of such trials. Trials assess-
ing the effect of a multilevel prenatal educational intervention also
including toxoplasmosis prevention among others, and measuring
the change in behavior or better pregnancy outcome as a com-
posite outcome, might be more practical and preferable. Finally,
we also suggest that in planning such trials, a checklist for good
quality reporting of cluster-randomized trials, for example, amod-
ified Consolidated Standards Of Reporting Trials (CONSORT)
(Campbell 2004), should be followed to ensure better quality and
to provide valuable information.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Carter 1989
Methods Cluster-randomized trial. Unit of randomization was the antenatal class
Participants 432 pregnant women attending 52 prenatal classes offered for free by a public health
agency in Ontario. Completed both the pre-test and the post-test questionnaire 285
women (122 in the experimental arm and 163 in the control arm). Loss to follow-up
was 34%
Interventions 10-minute teaching session during the first prenatal class on how to avoid toxoplasmosis
infection
Outcomes Pet hygiene behavior of cat owners.
Food hygiene behaviors.
Personal hygiene behaviors.
Notes A behavior change scoring system was developed: a woman gained 1 point for every
change toward a useful behavior, while she lost 1 point for every change toward a dan-
gerous behavior
The authors did not report raw data (number or proportion): only the significance test
data (P value) for differences were reported. We have contacted the authors for the
original data but have not yet received a reply
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not described in the publication.
Allocation concealment (selection bias) Low risk Not described in the publication.However,
as all the centers present in that jurisdic-
tional area were involved, an equal num-
ber of classes in each center received the
experimental and the control intervention,
and this is a cluster-randomized trial, thus
the units of randomization are the prenatal
groups, the lack of allocation concealment
is unlikely to influence the outcome
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Blinding of the women reported, blinding
of the personnel was not possible, but un-
likely to influence the outcome
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Carter 1989 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Measure of knowledge and behavior were
self-reported.
Incomplete outcome data (attrition bias)
All outcomes
High risk Losses to follow-up were 34% (432 women
completed the pretest questionnaire and
285 completed the post-test questionnaire)
: women in experimental group were more
likely to be lost at follow-up than women
in control group
Selective reporting (reporting bias) Unclear risk All of the pre-specified outcomes have been
reported. However, the study did not re-
port seroconversion rate during pregnancy,
which is an outcome of interest
Other bias Unclear risk Contamination between groups can not be
excluded.
Wallon 2006
Methods Cluster-randomized trial. Units of randomization were prenatal clinics
Participants 5023 seronegative pregnant women attending prenatal clinics in 7 counties in the area
of Lyon (France). Completed both the pre-test and the post-test questionnaire 2790
women (1953 in the experimental arm and 837 in the control arm). Loss to follow-up
was 44.5%
Interventions Physicians in experimental cities were instructed to give their patients:
- a 20-page brochure containing relevant information about different aspects of preg-
nancy, including 4 pages on toxoplasmosis prevention and transmission;
- an audiotape containing frequently asked questions during pregnancy, including ques-
tions on toxoplasmosis
Outcomes Knowledge and behavior change including:
- consumption of undercooked meat of any type;
- handwashing after contact with transmission factors (soil, raw meat, unwashed vegeta-
bles) and before meals
Seroconvertion for toxoplasmosis.
Notes Knowledge and behavior was measured through a questionnaire at baseline (during the
third and fourth months of pregnancy) and at follow-up (at delivery)
There was a large and differential loss-to-follow-up: completed the follow-up question-
naire and were therefore included in the analysis 60% of the women enrolled in the
experimental group and 48% of the women enrolled in the control group. Amultivariate
analysis was conducted but it was not specified if the statistical plan of analysis considered
to correct for cluster design
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Wallon 2006 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not described in the publication.
Allocation concealment (selection bias) Unclear risk Not described in the publication.
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Blinding of the women reported, blinding
of the personnel was not possible, but un-
likely to influence the outcome as the out-
come assessed by the personnel was sero-
conversion rate
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Measure of knowledge and behavior were
self-reported.
Incomplete outcome data (attrition bias)
All outcomes
High risk Overall losses to follow-up were 44.5%:
women in the control group were more
likely to be lost at follow-up (52% were
lost) than women in intervention group
(40% were lost)
Selective reporting (reporting bias) Low risk All of the study’s pre-specified outcomes
and all expected outcomes of interest to the
review (including seroconversion rate) have
been reported
Other bias Unclear risk Study method and statistical plan of anal-
ysis were not described in details, therefore
it is not possible to exclude other bias
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Breugelmans 2004 Not randomized. For details of study, see Table 1.
Molé 1992 Not randomized. For details of study, see Table 1.
Pawlowski 2001 Not randomized. For details of study, see Table 1.
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D A T A A N D A N A L Y S E S
Comparison 1. Brochure and an audiotape compared to standard care




participants Statistical method Effect size
1 Rate of toxoplasmosis
seroconversion during
pregnancy
1 3949 Risk Ratio (M-H, Fixed, 95% CI) 1.70 [0.56, 5.21]
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WH A T ’ S N E W
Last assessed as up-to-date: 31 May 2015.
Date Event Description
31 May 2015 New search has been performed Search updated and no new trial reports identified. ’Sum-
mary of findings’ table incorporated
31 May 2015 New citation required but conclusions have not changed Review updated.
H I S T O R Y
Protocol first published: Issue 4, 2006
Review first published: Issue 1, 2009
Date Event Description
15 January 2012 New citation required but conclusions have not changed This reviewhas been updated. The addition of onemore
included study has not changed the results and conclu-
sions
15 January 2012 New search has been performed Search updated. No new studies identified.
One study (Wallon 2006), previously classified as pend-
ing has been included. This review now contains two
included studies (involving a total of 5455 women)
The methods have been updated.
16 January 2008 Amended Converted to new review format.
C O N T R I B U T I O N S O F A U T H O R S
First version of the review: SimonaDiMario (SDM), Vittorio Basevi (VB) andDaniela Spettoli (DS)were responsible for the conception
of the study. SDM, DS, Carlo Gagliotti (CG) and Gianfranco Gori selected the studies and assessed the quality. SDM, DS and CG
collected and analyzed the data. VB, Nicola Magrini and Roberto D’Amico (RDA) provided input for writing the protocol and review.
All authors provided comments on earlier drafts, revised and approved the initial version of the review. SDM, CG and RDA assessed
the new studies for inclusion and performed the data extraction. SDM drafted the changes to the text. All authors provided comments,
revised and approved the updated version of the review.
For the 2015 update, Simona DiMario (SDM) rearranged the text of the review according to new standard suggested from theCochrane
Pregnancy and Childbirth Group, adding new paragraphs and additional other references; Vittorio Basevi (VB), Daniela Spettoli (DS)
and Carlo Gagliotti (CG) revised the text, Gianfranco Gori (GG), Nicola Magrini (NM) and Roberto D’Amico (RDA) read and
approved the final version of the review.
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D E C L A R A T I O N S O F I N T E R E S T
None known.
S O U R C E S O F S U P P O R T
Internal sources
• SaPeRiDoc, Direzione generale sanità e politiche sociali, Regione Emilia-Romagna, Bologna, Italy.
External sources
• UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human
Reproduction (HRP), Department of Reproductive Health and Research (RHR), World Health Organization, Switzerland.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The methods have been updated to reflect the latest Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011) and the
current standardmethods text of Cochrane Pregnancy and Childbirth Group. Two ’Summary of findings’ tables have been incorporated.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Hygiene [∗education]; Pregnancy Complications, Parasitic [∗prevention& control]; Prenatal Care [∗methods]; Randomized Controlled
Trials as Topic; Rare Diseases [parasitology; ∗prevention & control]; Toxoplasmosis, Congenital [∗prevention & control]
MeSH check words
Female; Humans; Pregnancy
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